Janet Fricker

All patients with metastatic breast cancer should have equal access to the best treatments and outcomes regardless of where they live in Europe. The EBCC14 manifesto, agreed at the 14th European Breast Cancer Conference (EBCC) on March 22 in Milan,…

The Cancer Grand Challenges initiative has announced the five global research teams who between them will receive $125 million to address unanswered questions. The winning teams, revealed in March, are addressing four major oncology challenges – solid tumours in children,…

Survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event than the general public. The study, published in the Journal of the American College of Cardiology 27 February, found risk of death after…

Stress causes neutrophils to form sticky ‘web-like structures’, making body tissues more susceptible to cancer metastasis. The study published in Cancer Cell, 22 February, demonstrated that the stress hormone glucocorticoid leads to the formation of neutrophil extracellular traps (NETs), known…

Lowering the dose and adjusting the schedule may help older adults with advanced cancer better tolerate chemotherapy. The cohort study, published in JAMA Network Open, February 15, found older patients with advanced cancer who underwent primary treatment modification had a…

Patients with major ‘adverse financial events’ – bankruptcies, liens (losing ownership of property pending payment of debt), or evictions – are more likely to have cancer diagnosed at an advanced stage than those without such serious financial problems. The US…

Increasing cardiorespiratory fitness rates by an average 3% a year or more is linked to a 35% reduced risk of men developing prostate cancer in comparison to those whose fitness levels declined by 3% over the same time period. The…

Between 1975 and 2019 breast cancer deaths dropped by 58% due to a combination of screening mammography and improved treatment. The US modelling study published in JAMA, 16th January 2024, found that by 2019 nearly one third of the decrease…

Only around one third of people with Lynch syndrome, the most common form of hereditary colorectal cancer, report taking aspirin as chemopreventive therapy. The survey, abstract 19, presented at the 2024 ASCO Gastrointestinal Cancers Symposium, held January 18–20, in San…

Immunotherapy is increasingly being initiated in the month prior to death in patients with stage IV non-small-cell lung cancer, melanoma, and renal cell carcinoma. The US study, published in JAMA Oncology, online January 4, showed the practice was more common…